Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cashflow Statement

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹1,491 Cr₹2,291 Cr₹1,674 Cr₹862 Cr₹202 Cr
Adjustment ₹30 Cr₹-22 Cr₹134 Cr₹102 Cr₹124 Cr
Changes In working Capital ₹646 Cr₹-200 Cr₹-309 Cr₹63 Cr₹-231 Cr
Cash Flow after changes in Working Capital ₹2,166 Cr₹2,069 Cr₹1,498 Cr₹1,027 Cr₹95 Cr
Cash Flow from Operating Activities ₹1,768 Cr₹1,697 Cr₹1,212 Cr₹849 Cr₹47 Cr
Cash Flow from Investing Activities ₹-2,082 Cr₹-1,415 Cr₹-1,033 Cr₹-477 Cr₹-5.30 Cr
Cash Flow from Financing Activities ₹298 Cr₹-211 Cr₹-247 Cr₹-363 Cr₹35 Cr
Net Cash Inflow / Outflow ₹-16 Cr₹72 Cr₹-68 Cr₹9.00 Cr₹76 Cr
Opening Cash & Cash Equivalents ₹120 Cr₹70 Cr₹132 Cr₹111 Cr₹26 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹95 Cr₹-22 Cr₹6.50 Cr₹12 Cr₹9.30 Cr
Closing Cash & Cash Equivalent ₹199 Cr₹120 Cr₹70 Cr₹132 Cr₹111 Cr

Compare Cashflow Statement of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,422.3 Cr -1% -4.2% -4.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,202.0 Cr 0.5% -2.9% 5% Stock Analytics
DIVIS LABORATORIES ₹264,141.0 Cr 5% 7.2% 49.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,402.0 Cr -0.5% -4.5% 28.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,868.0 Cr 2.7% 8.4% 5.1% Stock Analytics
CIPLA ₹111,650.0 Cr 2.4% 2.4% -12.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1%

-4.2%

-4.4%

SENSEX

2.8%

4.4%

-10.1%


You may also like the below Video Courses